Solid Biosciences Inc

(NASDAQ:SLDB)

Latest On Solid Biosciences Inc (SLDB):

Date/Time Type Description Signal Details
2023-05-11 10:26 ESTNewsSolid Biosciences reports Q1 resultsN/A
2023-03-24 00:27 ESTNewsSolid Biosciences reports Q4 resultsN/A
2023-01-11 14:23 ESTNewsSolid Biosciences, Phlox team up to develop precision drugs for heart diseasesN/A
2023-01-09 20:25 ESTNewsKevin Tan is the new finance chief at Solid BiosciencesN/A
2022-11-10 23:10 ESTNewsSolid Biosciences reports Q3 resultsN/A
2022-10-27 14:21 ESTNewsSolid Biosciences announces 1-for-15 reverse stock splitN/A
2022-09-30 23:08 ESTNewsSolid Biosciences to acquire gene therapy company AavantiBioN/A
2022-09-30 23:08 ESTNewsSolid Bio adds 14% as JPMorgan upgrades on AavantiBio buyoutN/A
2022-08-11 15:31 ESTNewsSolid Biosciences reports Q2 resultsN/A
2022-04-30 23:05 ESTNewsSolid Biosciences Inc. (SLDB) CEO Ilan Ganot on Q1 2022 Results - Earnings Call TranscriptN/A
2021-11-03 18:52 ESTNewsWarning: SLDB is at high risk of performing badlyN/A
2021-11-03 18:51 ESTNewsSolid Biosciences EPS beats by $18.20, beats on revenueN/A
2021-11-02 23:10 ESTNewsRegenxbio-Solid Biosciences' PDC releases white paper for AAV gene therapy developmentN/A
2021-10-09 09:35 ESTNewsSolid Biosciences Investor Presentation - SlideshowN/A
2021-09-29 23:16 ESTNewsSolid Biosciences posts additional pulmonary function data from early-stage DMD trialN/A
2021-09-23 11:54 ESTNewsSolid Bio gains 11% on positive SGT-001 data after 1.5 years in Duchenne Muscular Dystrophy trialN/A
2021-09-22 06:01 ESTNewsSolid Biosciences surges ahead of presentation on Duchenne muscular dystrophy trialN/A
2021-08-17 00:41 ESTNewsSolid Biosciences EPS beats by $0.01, beats on revenueN/A
2021-07-22 00:53 ESTNewsLMNL, CLAR, FIXX and PETS among after-hours moversN/A
2021-04-11 14:18 ESTNewsSolid Biosciences: Future More Uncertain Than SolidN/A
2021-03-29 17:47 ESTNewsSuvretta Capital discloses 5.4% stake in Solid Biosciences; shares rise 6% post-marketN/A
2021-03-26 15:29 ESTNewsSolid Biosciences (SLDB) Investor Presentation - SlideshowN/A
2021-03-20 02:25 ESTNewsSolid Biosciences prices $125M capital raiseN/A
2021-03-18 09:41 ESTAnalyst RatingThe Analyst Target Price has increased from $9.92 to $11.17.Buy
2021-03-18 05:27 ESTNewsSolid Biosciences enters $85M capital raiseN/A
2021-03-17 21:50 ESTAnalyst RatingThe Analyst Target Price has increased from $7.75 to $9.92.Buy
2021-03-17 08:13 ESTNewsSolid Biosciences reports mid-stage data in Duchenne muscular dystrophy trialN/A
2021-03-17 08:12 ESTNewsBiogen expected to receive FDA nod for Alzheimer’s therapy and Solid Bioscience upgraded in today’s analyst actionN/A
2021-03-17 08:11 ESTNewsSolid Biosciences upgraded at SVB Leerink on DMD trial dataN/A
2021-03-16 22:02 ESTEarnings EstimateAn EPS average of -$0.96 is estimated for the 2022 year.Sell
2021-03-16 22:02 ESTEarnings EstimateAn EPS average of -$0.30 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-10 12:19 ESTAnalyst RatingThe Analyst Target Price has increased from $6.7 to $7.75.Neutral
2021-01-11 22:54 ESTNewsSolid Bio sinks 13% after Sarepta data misses goalN/A
2021-01-11 04:33 ESTAnalyst RatingThe Analyst Target Price has increased from $5.7 to $6.7.Neutral
2021-01-08 07:21 ESTNewsSoild Bio sinks 13% after Sarepta data misses goalN/A
2021-01-04 04:54 ESTAnalyst RatingThe Analyst Target Price has increased from $4.7 to $5.7.Neutral
2020-12-11 11:44 ESTNewsSolid Biosciences launches $90M private placement, shares up 23% premarket.N/A
2020-11-26 21:34 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 00:28 ESTNewsSolid Biosciences: Does Not Look Like A Solid Investment Given Its Unsatisfactory Trial DataN/A
2020-11-10 05:04 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 05:10 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 14:19 ESTNewsSolid Biosciences' (SLDB) CEO Ilan Ganot on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-08 00:54 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:08 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 08:51 ESTEarnings EstimateAn EPS average of -$0.23 is estimated for the quarter ending on March 31, 2021.Buy
2020-11-05 15:04 ESTNewsSolid Biosciences EPS misses by $0.10N/A
2020-10-24 08:47 ESTNewsUltragenyx, Solid Biosciences in pact for Duchenne gene therapiesN/A
2020-10-03 09:57 ESTAnalyst RatingThe Analyst Target Price has increased from $3 to $4.7.Neutral
2020-10-01 23:45 ESTNewsFDA lifts hold on Solid Bio's Duchenne study; shares rocket 61%N/A
2020-10-01 23:44 ESTNewsChardan raises Solid Biosciences price target 250%N/A

About Solid Biosciences Inc (SLDB):

Solid Biosciences Inc., a life science company, engages in developing therapies for duchenne muscular dystrophy (DMD) in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to derive functional dystrophin protein expression in patients' muscles. Its portfolio also comprises Anti-LTBP4, a complementary disease modifying program that identifies and develops a monoclonal antibody intended to reduce fibrosis and inflammation by targeting and stabilizing the LTBP4 protein. In addition, the company engages in developing biomarkers and sensors; and Solid Suit program that includes the development of wearable assistive devices that focus on providing functional and therapeutic benefits. Solid Biosciences Inc. has strategic collaboration with Ultragenyx to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.

SLDB Quotes by TradingView

See Advanced Chart

General

  • Name Solid Biosciences Inc
  • Symbol SLDB
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 121
  • Fiscal Year EndDecember
  • IPO Date2018-01-26
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.solidbio.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 4.29
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Current Year EPS Estimate -$1.55
  • Next Year EPS Estimate -$1.31
  • Next Quarter EPS Estimate -$0.26
  • Return on Assets -71%
  • Return on Equity -151%
  • Earnings Per Share -$2.80
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 515.04 million
  • EBITDA -96527000
  • Analyst Target Price $11.17
  • Book Value Per Share $1.56
View More

Share Statistics

  • Shares Outstanding 85.13 million
  • Shares Float 1.78 million
  • % Held by Insiders 3232%
  • % Held by Institutions 67.38%
  • Shares Short 2.75 million
  • Shares Short Prior Month 2.22 million
  • Short Ratio 2.02
  • Short % of Float 4%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 1.17
  • 52 Week High $11.58
  • 52 Week Low $1.93
  • 50 Day Moving Average 8.14
  • 200 Day Moving Average 5.2
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Solid Biosciences Inc (SLDB) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Solid Biosciences Inc (SLDB) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31-$0.31-$0.348.82%
2020-09-302020-11-05$N/A-$0.44-$0.37-20.55%
2020-06-302020-08-06$N/A-$0.39-$0.5021.47%
2020-03-312020-05-07$N/A-$0.52-$0.533.34%
2019-12-312020-03-12$N/A-$0.65-$0.60-8.24%
2019-09-302019-11-12$N/A-$0.67-$0.67-0.4%
2019-06-302019-08-14$N/A-$0.76-$0.771.66%
2019-03-312019-05-13$N/A-$0.85-$0.63-35.22%
2018-12-312019-03-13$N/A-$0.64-$0.61-5.51%
2018-09-302018-11-13$N/A-$0.55-$0.561.49%
2018-06-302018-08-10$N/A-$0.52-$0.51-2.04%
2018-03-312018-05-10$N/A-$0.54-$0.41-30.94%
2017-12-312018-03-29$N/A-$0.89-$0.59-51.7%

Solid Biosciences Inc (SLDB) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development N/A N/A 19.67 million 27.07 million 22.79 million
Income Before Tax N/A N/A -26.69 million -31.86 million -29.26 million
Selling General Administrative N/A N/A 5.25 million 5.26 million 6.93 million
Gross Profit N/A N/A N/A N/A N/A
Ebit N/A N/A -23.89 million -32.33 million -29.72 million
Operating Income N/A N/A -24.92 million -32.33 million -29.72 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A -1.94 million 469000 462000
Net Income From Continuing Operations N/A N/A -26.69 million -31.86 million -29.26 million
Net Income Applicable to Common Shares -21.25 million -18.99 million -26.69 million -31.86 million -29.26 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments -80000 N/A N/A 3.5 million 4.61 million
Change to Liabilities N/A 417000 -4.31 million 3.77 million -2.43 million
Total Cash Flow from Investing Activities N/A 322000 6.42 million 2.86 million 3.96 million
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A N/A -287000 58.16 million
Change to Operating Activities N/A 924000 -2.38 million 2.67 million 8.3 million
Change in Cash -15.64 million N/A N/A -18.68 million 42.88 million
Total Cash from Operating Activities -15.56 million -13.07 million -29.27 million -21.25 million -19.24 million
Depreciation 766000 N/A N/A 806000 764000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A N/A N/A -287000 8.84 million
Change to Net Income N/A 3.24 million 3.08 million 3.37 million 3.38 million
Capital Expenditures 80000 N/A N/A 645000 650000
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities N/A N/A 17.5 million 23.42 million 22.4 million
Total Stockholder Equity N/A N/A 56.46 million 80.05 million 108.53 million
Other Current Liabilities N/A N/A N/A 52000 221000
Total Assets N/A N/A 73.96 million 103.47 million 130.93 million
Common Stock 48000 48000 48000 48000 48000
Other Current Assets N/A N/A N/A 1.29 million 5.26 million
Retained Earnings -383.21 million -361.96 million -342.97 million -316.28 million -284.42 million
Other Liabilities N/A N/A N/A N/A N/A
Other Assets 536000 536000 536000 536000 536000
Cash N/A N/A 53.19 million 76.04 million 94.72 million
Total Current Liabilities 14.77 million N/A 12.88 million 18.28 million 16.75 million
Other Stockholder Equity N/A N/A -1000 1000 -2000
Property, Plant & Equipment 12.82 million 13.89 million 15.52 million 16.63 million 16.9 million
Total Current Assets 27.16 million N/A 57.9 million 86.3 million 113.49 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 22.23 million 40.71 million 56.46 million 80.05 million 108.53 million
Short Term Investments N/A N/A 400000 7.48 million 10.94 million
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 4.08 million N/A 2.38 million 7.12 million 3.21 million

Solid Biosciences Inc (SLDB) Chart:

Solid Biosciences Inc (SLDB) News:

Below you will find a list of latest news for Solid Biosciences Inc (SLDB) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Solid Biosciences Inc (SLDB) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-11-2110CALL0 0461.53TRUE00
2025-11-2123.78CALL0 1273.1TRUE00
2025-11-2130CALL0 00TRUE00
2025-11-2142.5CALL0 00TRUE00
2025-11-2150CALL0 0585.84TRUE00
2025-11-2160.85CALL0 16246.26FALSE00
2025-11-2170.25CALL0 291175.33FALSE00
2025-11-2180.25CALL0 56199.84FALSE00
2025-11-2190CALL0 0356.08FALSE00
2025-11-21100.55CALL0 1385.06FALSE00
2025-11-21110CALL0 0455.5FALSE00
2025-11-2110PUT0 00FALSE00
2025-11-2120PUT0 0728.22FALSE00
2025-11-2130.05PUT0 20422.3FALSE00
2025-11-2140PUT0 0375FALSE00
2025-11-2150.48PUT160 290128.54FALSE0.352.69
2025-11-2160.7PUT0 101165.48TRUE00
2025-11-2171.16PUT0 1271.04TRUE00
2025-11-2180PUT0 00TRUE00
2025-11-2190PUT0 00TRUE00
2025-11-21100PUT0 00TRUE00
2025-11-21110PUT0 00TRUE00
2025-12-192.53.01CALL0 57216.45TRUE00
2025-12-1940CALL0 0295.47TRUE00
2025-12-1951.2CALL0 463145.04TRUE00
2025-12-1960CALL0 0725.86FALSE00
2025-12-197.50.75CALL0 314174.19FALSE00
2025-12-1990.3CALL0 1359.42FALSE00
2025-12-19100.15CALL15 98138.2FALSE-0.05-0.25
2025-12-1912.50.5CALL0 0276.09FALSE00
2025-12-192.50.15PUT0 3367.53FALSE00
2025-12-1940PUT0 01048.2FALSE00
2025-12-1950.75PUT0 59101.97FALSE00
2025-12-1961.17PUT0 5150.16TRUE00
2025-12-197.52.6PUT0 1254.03TRUE00
2025-12-1990PUT0 0118.42TRUE00
2025-12-19100PUT0 00TRUE00
2025-12-1912.50PUT0 00TRUE00
2026-01-162.53.7CALL0 25194.6TRUE00
2026-01-1642.25CALL0 10816.04TRUE00
2026-01-1652CALL0 4683168.55TRUE00
2026-01-1661CALL0 17236.24FALSE00
2026-01-167.50.8CALL0 89270FALSE00
2026-01-1690CALL0 0666.44FALSE00
2026-01-16100.4CALL1 80146.89FALSE0.40
2026-01-1612.50.2CALL0 51633.25FALSE00
2026-01-162.50PUT0 0290.59FALSE00
2026-01-1640PUT0 00FALSE00
2026-01-1650PUT0 0193.86FALSE00
2026-01-1660PUT0 0218.19TRUE00
2026-01-167.50PUT0 0136.92TRUE00
2026-01-1690PUT0 0120.57TRUE00
2026-01-16100PUT0 0126.59TRUE00
2026-01-1612.50PUT0 00TRUE00
2026-03-202.53.3CALL0 29260.1TRUE00
2026-03-2040CALL0 0287.97TRUE00
2026-03-2052.85CALL0 40203.24TRUE00
2026-03-2061.95CALL0 2628.67FALSE00
2026-03-207.50.05CALL0 33643.96FALSE00
2026-03-2090CALL0 0171.57FALSE00
2026-03-20100.9CALL0 140127.77FALSE00
2026-03-2012.50.48CALL0 80175.76FALSE00
2026-03-202.50PUT0 0352.96FALSE00
2026-03-2040PUT0 00FALSE00
2026-03-2051.25PUT0 15821.18FALSE00
2026-03-2061.1PUT0 5205.7TRUE00
2026-03-207.50PUT0 0109.01TRUE00
2026-03-2090PUT0 0110.73TRUE00
2026-03-20105.1PUT0 1107.43TRUE00
2026-03-2012.50PUT0 0111.2TRUE00
2026-06-1810CALL0 0203.54TRUE00
2026-06-1820CALL0 0168.84TRUE00
2026-06-1833.06CALL0 2133.52TRUE00
2026-06-1840CALL0 0130.59TRUE00
2026-06-1850CALL0 0156.94TRUE00
2026-06-1862.1CALL0 5160.73FALSE00
2026-06-1870CALL0 0496.17FALSE00
2026-06-1880CALL0 0503.16FALSE00
2026-06-1890CALL0 0509.19FALSE00
2026-06-18100CALL0 0210.64FALSE00
2026-06-18110CALL0 0519.23FALSE00
2026-06-18120CALL0 0523.49FALSE00
2026-06-1810PUT0 0609.13FALSE00
2026-06-1820PUT0 00FALSE00
2026-06-1830PUT0 00FALSE00
2026-06-1840PUT0 00FALSE00
2026-06-1850PUT0 0180.6FALSE00
2026-06-1860PUT0 0128.04TRUE00
2026-06-1870PUT0 0106.4TRUE00
2026-06-1880PUT0 0104.07TRUE00
2026-06-1890PUT0 0108.57TRUE00
2026-06-18100PUT0 0111.26TRUE00
2026-06-18110PUT0 0105.65TRUE00
2026-06-18120PUT0 0101.2TRUE00

Latest SLDB Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$0.6408
Jun 13, 2022 7:59 PM EST28$0.651
Jun 13, 2022 7:59 PM EST100$0.6485
Jun 13, 2022 7:59 PM EST21$0.6516
Jun 13, 2022 7:59 PM EST22$0.6624

Solid Biosciences Inc (SLDB) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924320017156/0000899243-20-017156-index.htm
2019-03-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1707502/000000000019004753/0000000000-19-004753-index.htm
2019-09-04UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1707502/000000000019013134/0000000000-19-013134-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1707502/000087504519000009/0000875045-19-000009-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924318030087/0000899243-18-030087-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924318030088/0000899243-18-030088-index.htm
2018-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924318031200/0000899243-18-031200-index.htm
2018-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924318031202/0000899243-18-031202-index.htm
2018-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924318031204/0000899243-18-031204-index.htm
2018-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924318031205/0000899243-18-031205-index.htm
2018-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924318031207/0000899243-18-031207-index.htm
2018-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924318031208/0000899243-18-031208-index.htm
2018-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924318031211/0000899243-18-031211-index.htm
2018-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924318031228/0000899243-18-031228-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319000269/0000899243-19-000269-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319000739/0000899243-19-000739-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319000742/0000899243-19-000742-index.htm
2019-01-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319000970/0000899243-19-000970-index.htm
2019-01-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319000971/0000899243-19-000971-index.htm
2019-01-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319000973/0000899243-19-000973-index.htm
2019-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319001270/0000899243-19-001270-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319001954/0000899243-19-001954-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319001955/0000899243-19-001955-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319001956/0000899243-19-001956-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319001957/0000899243-19-001957-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319001959/0000899243-19-001959-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319001960/0000899243-19-001960-index.htm
2019-02-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319002338/0000899243-19-002338-index.htm
2019-02-013/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319002340/0000899243-19-002340-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319004375/0000899243-19-004375-index.htm
2019-03-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319006464/0000899243-19-006464-index.htm
2019-03-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319009195/0000899243-19-009195-index.htm
2019-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319013080/0000899243-19-013080-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319017134/0000899243-19-017134-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319017135/0000899243-19-017135-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319017188/0000899243-19-017188-index.htm
2019-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924319020588/0000899243-19-020588-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924320017092/0000899243-20-017092-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924320017154/0000899243-20-017154-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000089924320017156/0000899243-20-017156-index.htm
2019-08-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1707502/000093583619000407/0000935836-19-000407-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1707502/000093583620000135/0000935836-20-000135-index.htm
2020-11-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1707502/000093583620000595/0000935836-20-000595-index.htm
2018-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000101297518001285/0001012975-18-001285-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000101297519000502/0001012975-19-000502-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1707502/000110465920021938/0001104659-20-021938-index.htm
2019-05-03DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1707502/000114036119008386/0001140361-19-008386-index.htm
2019-05-03DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1707502/000114036119008388/0001140361-19-008388-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1707502/000114036120009881/0001140361-20-009881-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1707502/000114036120009884/0001140361-20-009884-index.htm
2020-05-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1707502/000114036120012241/0001140361-20-012241-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1707502/000114420419008169/0001144204-19-008169-index.htm
2019-07-30SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1707502/000114420419036692/0001144204-19-036692-index.htm
2019-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1707502/000119312519003979/0001193125-19-003979-index.htm
2019-01-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1707502/000119312519018968/0001193125-19-018968-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1707502/000119312519032113/0001193125-19-032113-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1707502/000119312519040820/0001193125-19-040820-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1707502/000119312519040941/0001193125-19-040941-index.htm
2019-03-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1707502/000119312519065709/0001193125-19-065709-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1707502/000119312519072676/0001193125-19-072676-index.htm
2019-03-13S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1707502/000119312519072709/0001193125-19-072709-index.htm
2019-03-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1707502/000119312519075824/0001193125-19-075824-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1707502/000119312519145404/0001193125-19-145404-index.htm
2019-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1707502/000119312519173665/0001193125-19-173665-index.htm
2019-07-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1707502/000119312519204157/0001193125-19-204157-index.htm
2019-07-30SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1707502/000119312519207100/0001193125-19-207100-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1707502/000119312519220535/0001193125-19-220535-index.htm
2019-09-03S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1707502/000119312519235866/0001193125-19-235866-index.htm
2019-10-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1707502/000119312519266639/0001193125-19-266639-index.htm
2019-10-23S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1707502/000119312519272564/0001193125-19-272564-index.htm
2019-10-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1707502/000119312519272578/0001193125-19-272578-index.htm
2019-10-28424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1707502/000119312519276191/0001193125-19-276191-index.htm
2019-12-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1707502/000119312519316730/0001193125-19-316730-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1707502/000119312520004274/0001193125-20-004274-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1707502/000119312520038071/0001193125-20-038071-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1707502/000119312520038388/0001193125-20-038388-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1707502/000119312520070917/0001193125-20-070917-index.htm
2020-03-1310-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1707502/000119312520073038/0001193125-20-073038-index.htm
2020-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1707502/000119312520108669/0001193125-20-108669-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1707502/000119312520135602/0001193125-20-135602-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1707502/000119312520171845/0001193125-20-171845-index.htm
2020-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1707502/000119312520198729/0001193125-20-198729-index.htm
2020-08-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1707502/000119312520211250/0001193125-20-211250-index.htm
2020-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1707502/000119312520260507/0001193125-20-260507-index.htm
2020-10-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1707502/000119312520274925/0001193125-20-274925-index.htm
2020-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1707502/000119312520276085/0001193125-20-276085-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1707502/000119312520286209/0001193125-20-286209-index.htm
2020-11-06SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1707502/000119312520287986/0001193125-20-287986-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919119037117/0001209191-19-037117-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919119037121/0001209191-19-037121-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919119037122/0001209191-19-037122-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919119037123/0001209191-19-037123-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919119037124/0001209191-19-037124-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919119037127/0001209191-19-037127-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919119037130/0001209191-19-037130-index.htm
2019-07-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919119041954/0001209191-19-041954-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919119043479/0001209191-19-043479-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919119043481/0001209191-19-043481-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919119043483/0001209191-19-043483-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919119043485/0001209191-19-043485-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919119043487/0001209191-19-043487-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919119043491/0001209191-19-043491-index.htm
2019-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919119045880/0001209191-19-045880-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120000997/0001209191-20-000997-index.htm
2020-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120005404/0001209191-20-005404-index.htm
2020-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120005408/0001209191-20-005408-index.htm
2020-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120005410/0001209191-20-005410-index.htm
2020-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120005412/0001209191-20-005412-index.htm
2020-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120005414/0001209191-20-005414-index.htm
2020-02-124/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120008909/0001209191-20-008909-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120008912/0001209191-20-008912-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120009823/0001209191-20-009823-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120018883/0001209191-20-018883-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120018892/0001209191-20-018892-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120018909/0001209191-20-018909-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120018918/0001209191-20-018918-index.htm
2020-04-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120024597/0001209191-20-024597-index.htm
2020-04-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120024599/0001209191-20-024599-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120037558/0001209191-20-037558-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120037560/0001209191-20-037560-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120037564/0001209191-20-037564-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120037576/0001209191-20-037576-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120037585/0001209191-20-037585-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120037591/0001209191-20-037591-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120037594/0001209191-20-037594-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120037688/0001209191-20-037688-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120037691/0001209191-20-037691-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120037696/0001209191-20-037696-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120037698/0001209191-20-037698-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120043949/0001209191-20-043949-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120043952/0001209191-20-043952-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120043957/0001209191-20-043957-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120043961/0001209191-20-043961-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120043981/0001209191-20-043981-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120046769/0001209191-20-046769-index.htm
2020-09-144/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120050272/0001209191-20-050272-index.htm
2020-10-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000120919120056343/0001209191-20-056343-index.htm
2019-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1707502/000156459019007462/0001564590-19-007462-index.htm
2019-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1707502/000156459019018869/0001564590-19-018869-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1707502/000156459019031964/0001564590-19-031964-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1707502/000156459019042546/0001564590-19-042546-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1707502/000156459020010247/0001564590-20-010247-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1707502/000156459020022357/0001564590-20-022357-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1707502/000156459020037207/0001564590-20-037207-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1707502/000156459020050874/0001564590-20-050874-index.htm
2019-07-31DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000170750219000002/0001707502-19-000002-index.htm
2020-10-26DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1707502/000170750220000001/0001707502-20-000001-index.htm
2019-03-19EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1707502/999999999519000469/9999999995-19-000469-index.htm
2019-10-25EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1707502/999999999519002396/9999999995-19-002396-index.htm

Solid Biosciences Inc (SLDB) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Solid Biosciences Inc (SLDB). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 3232%
Institutional Ownership: 6738%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-05-08Juan Andrey ZarurDirectorSell8,000.0010.0080,039.2010,189.00https://www.sec.gov/Archives/edgar/data/1707502/000089924319013080/0000899243-19-013080-index.htm
2019-07-25Ilan GanotCEO & PresidentBuy21,505.004.6599,998.251,123,631.00https://www.sec.gov/Archives/edgar/data/1707502/000120919119043483/0001209191-19-043483-index.htm
2020-07-28Ilan GanotCEO & PresidentSell11,124.002.4226,910.071,148,007.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120043949/0001209191-20-043949-index.htm
2020-07-27Ilan GanotCEO & PresidentBuy35,500.001,159,131.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120043949/0001209191-20-043949-index.htm
2019-07-25Carl Ashley MorrisChief Scientific OfficerBuy21,505.004.6599,998.25133,050.00https://www.sec.gov/Archives/edgar/data/1707502/000120919119043485/0001209191-19-043485-index.htm
2020-06-16LYNETTE HERSCHAChief Legal OfficerBuy75,000.00150,000.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120037688/0001209191-20-037688-index.htm
2019-01-04Pedro Alvaro AmorrortuChief Operating OfficerSell9,000.0030.07270,619.20158,046.00https://www.sec.gov/Archives/edgar/data/1707502/000089924319000739/0000899243-19-000739-index.htm
2020-07-28LYNETTE HERSCHAChief Legal OfficerSell5,141.002.4212,437.62160,859.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120043952/0001209191-20-043952-index.htm
2020-07-27LYNETTE HERSCHAChief Legal OfficerBuy16,000.00166,000.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120043952/0001209191-20-043952-index.htm
2018-12-03Pedro Alvaro AmorrortuChief Operating OfficerSell300.0032.389,714.99167,046.00https://www.sec.gov/Archives/edgar/data/1707502/000089924318030088/0000899243-18-030088-index.htm
2018-12-03Pedro Alvaro AmorrortuChief Operating OfficerSell5,693.0031.44178,996.46167,346.00https://www.sec.gov/Archives/edgar/data/1707502/000089924318030088/0000899243-18-030088-index.htm
2018-12-03Pedro Alvaro AmorrortuChief Operating OfficerSell3,007.0030.2090,822.83173,039.00https://www.sec.gov/Archives/edgar/data/1707502/000089924318030088/0000899243-18-030088-index.htm
2020-03-11Joel Solomon Zev SchneiderChief Technology OfficerBuy75,000.00201,656.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120018918/0001209191-20-018918-index.htm
2020-03-11Carl Ashley MorrisChief Scientific OfficerBuy75,000.00208,050.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120018909/0001209191-20-018909-index.htm
2018-12-03Jorge Armando QuirozChief Medical OfficerSell1,370.0032.2444,174.42228,092.00https://www.sec.gov/Archives/edgar/data/1707502/000089924318030087/0000899243-18-030087-index.htm
2018-12-03Jorge Armando QuirozChief Medical OfficerSell31,426.0031.41987,147.23229,462.00https://www.sec.gov/Archives/edgar/data/1707502/000089924318030087/0000899243-18-030087-index.htm
2020-02-10Ilan GanotCEO & PresidentBuy2,430.002,430.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120008912/0001209191-20-008912-index.htm
2020-03-11Jennifer Lynn ZiolkowskiCFO, Treasurer & Asst. SecyBuy75,000.00244,700.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120018892/0001209191-20-018892-index.htm
2018-12-03Jorge Armando QuirozChief Medical OfficerSell6,154.0030.21185,900.03260,888.00https://www.sec.gov/Archives/edgar/data/1707502/000089924318030087/0000899243-18-030087-index.htm
2018-12-03Jorge Armando QuirozChief Medical OfficerSell1,200.0029.9435,923.68267,042.00https://www.sec.gov/Archives/edgar/data/1707502/000089924318030087/0000899243-18-030087-index.htm
2020-06-16Joel Solomon Zev SchneiderChief Technology OfficerBuy75,000.00276,656.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120037696/0001209191-20-037696-index.htm
2020-06-16Carl Ashley MorrisChief Scientific OfficerBuy75,000.00283,050.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120037691/0001209191-20-037691-index.htm
2020-07-28Joel Solomon Zev SchneiderChief Technology OfficerSell4,041.002.429,775.58284,115.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120043981/0001209191-20-043981-index.htm
2020-07-27Joel Solomon Zev SchneiderChief Technology OfficerBuy11,500.00288,156.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120043981/0001209191-20-043981-index.htm
2020-07-28Carl Ashley MorrisChief Scientific OfficerSell3,591.002.428,689.14290,959.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120043961/0001209191-20-043961-index.htm
2020-07-27Carl Ashley MorrisChief Scientific OfficerBuy11,500.00294,550.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120043961/0001209191-20-043961-index.htm
2020-06-16Jennifer Lynn ZiolkowskiCFO, Treasurer & Asst. SecyBuy75,000.00319,700.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120037698/0001209191-20-037698-index.htm
2020-02-12Ilan GanotCEO & PresidentBuy800.003,230.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120009823/0001209191-20-009823-index.htm
2020-07-28Jennifer Lynn ZiolkowskiCFO, Treasurer & Asst. SecySell3,591.002.428,686.99327,609.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120043957/0001209191-20-043957-index.htm
2020-07-27Jennifer Lynn ZiolkowskiCFO, Treasurer & Asst. SecyBuy11,500.00331,200.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120043957/0001209191-20-043957-index.htm
2019-01-14Matthew Bennett ArnoldDirectorSell3,300.0032.20106,258.023,386,293.00https://www.sec.gov/Archives/edgar/data/1707502/000089924319001270/0000899243-19-001270-index.htm
2019-01-14Matthew Bennett ArnoldDirectorSell1,700.0031.6053,723.743,389,593.00https://www.sec.gov/Archives/edgar/data/1707502/000089924319001270/0000899243-19-001270-index.htm
2019-01-07Matthew Bennett ArnoldDirectorSell5,000.0030.08150,406.503,391,293.00https://www.sec.gov/Archives/edgar/data/1707502/000089924319000742/0000899243-19-000742-index.htm
2019-07-25Sukumar NagendranDirectorBuy32,258.004.65149,999.7034,258.00https://www.sec.gov/Archives/edgar/data/1707502/000120919119043487/0001209191-19-043487-index.htm
2019-03-28Boxer Capital, LLC10% Share HolderSell60,000.009.53571,800.003,473,272.00https://www.sec.gov/Archives/edgar/data/1707502/000089924319009195/0000899243-19-009195-index.htm
2020-08-13Ilan GanotCEO & PresidentSell299.002.44729.833,483.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120046769/0001209191-20-046769-index.htm
2019-07-25Matthew Bennett ArnoldDirectorBuy677,419.004.653,149,998.353,500,997.00https://www.sec.gov/Archives/edgar/data/1707502/000120919119043479/0001209191-19-043479-index.htm
2019-03-27Boxer Capital, LLC10% Share HolderSell115,000.009.601,104,000.003,533,272.00https://www.sec.gov/Archives/edgar/data/1707502/000089924319009195/0000899243-19-009195-index.htm
2019-03-26Boxer Capital, LLC10% Share HolderSell275,000.0010.082,772,000.003,648,272.00https://www.sec.gov/Archives/edgar/data/1707502/000089924319009195/0000899243-19-009195-index.htm
2020-08-12Ilan GanotCEO & PresidentBuy800.003,737.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120046769/0001209191-20-046769-index.htm
2019-07-30Adam KoppelDirectorBuy1,881,720.004.658,749,998.003,871,164.00https://www.sec.gov/Archives/edgar/data/1707502/000089924319020588/0000899243-19-020588-index.htm
2019-07-25Rajeev M. ShahDirectorBuy1,881,720.004.658,749,998.004,571,164.00https://www.sec.gov/Archives/edgar/data/1707502/000120919119043491/0001209191-19-043491-index.htm
2019-07-25Martin I FreedDirectorBuy53,763.004.65249,997.9553,763.00https://www.sec.gov/Archives/edgar/data/1707502/000120919119043481/0001209191-19-043481-index.htm
2019-07-25PERCEPTIVE ADVISORS LLCDirectorBuy2,822,581.004.6513,125,001.656,749,803.00https://www.sec.gov/Archives/edgar/data/1707502/000101297519000502/0001012975-19-000502-index.htm
2020-03-11LYNETTE HERSCHAChief Legal OfficerBuy75,000.0075,000.00https://www.sec.gov/Archives/edgar/data/1707502/000120919120018883/0001209191-20-018883-index.htm